<?xml version="1.0" encoding="UTF-8"?>
<ref id="B3-marinedrugs-17-00374" class="ref">
 <label class="label">3.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Arrese</surname>
    <given-names class="given-names">M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Cabrera</surname>
    <given-names class="given-names">D.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Kalergis</surname>
    <given-names class="given-names">A.M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Feldstein</surname>
    <given-names class="given-names">A.E.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Innate Immunity and Inflammation in NAFLD/NASH</article-title>
  <source class="source">Dig. Dis. Sci.</source>
  <year class="year">2016</year>
  <volume class="volume">61</volume>
  <fpage class="fpage">1294</fpage>
  <lpage class="lpage">1303</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1007/s10620-016-4049-x</pub-id>
  <?supplied-pmid 26841783?>
  <pub-id pub-id-type="pmid" class="pub-id">26841783</pub-id>
 </element-citation>
</ref>
